Detalhe da pesquisa
1.
A Synergistic Interaction between Chk1- and MK2 Inhibitors in KRAS-Mutant Cancer.
Cell
; 162(1): 146-59, 2015 Jul 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-26140595
2.
Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing.
Cell
; 150(6): 1107-20, 2012 Sep 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-22980975
3.
Retraction Notice to: Cytohesins Are Cytoplasmic ErbB Receptor Activators.
Cell
; 165(5): 1293, 2016 May 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-27203114
4.
Cytohesins are cytoplasmic ErbB receptor activators.
Cell
; 143(2): 201-11, 2010 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20946980
5.
Depletion of histone methyltransferase KMT9 inhibits lung cancer cell proliferation by inducing non-apoptotic cell death.
Cancer Cell Int
; 20: 52, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32095117
6.
AATF/Che-1 acts as a phosphorylation-dependent molecular modulator to repress p53-driven apoptosis.
EMBO J
; 31(20): 3961-75, 2012 Oct 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-22909821
7.
High-throughput oncogene mutation profiling in human cancer.
Nat Genet
; 39(3): 347-51, 2007 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-17293865
8.
CGARS: cancer genome analysis by rank sums.
Bioinformatics
; 30(9): 1295-6, 2014 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24413525
9.
Bronchial and peripheral murine lung carcinomas induced by T790M-L858R mutant EGFR respond to HKI-272 and rapamycin combination therapy.
Cancer Cell
; 12(1): 81-93, 2007 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-17613438
10.
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1.
Nature
; 462(7269): 108-12, 2009 Nov 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-19847166
11.
A framework for identification of actionable cancer genome dependencies in small cell lung cancer.
Proc Natl Acad Sci U S A
; 109(42): 17034-9, 2012 Oct 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-23035247
12.
Sensitive mutation detection in heterogeneous cancer specimens by massively parallel picoliter reactor sequencing.
Nat Med
; 12(7): 852-5, 2006 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-16799556
13.
Characterizing the cancer genome in lung adenocarcinoma.
Nature
; 450(7171): 893-8, 2007 Dec 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-17982442
14.
Systematic screen for tyrosine kinase rearrangements identifies a novel C6orf204-PDGFRB fusion in a patient with recurrent T-ALL and an associated myeloproliferative neoplasm.
Genes Chromosomes Cancer
; 51(1): 54-65, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-21938754
15.
Counteracting lineage-specific transcription factor network finely tunes lung adeno-to-squamous transdifferentiation through remodeling tumor immune microenvironment.
Natl Sci Rev
; 10(4): nwad028, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-37051524
16.
Characterizing Evolutionary Dynamics Reveals Strategies to Exhaust the Spectrum of Subclonal Resistance in EGFR-Mutant Lung Cancer.
Cancer Res
; 83(15): 2471-2479, 2023 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37289018
17.
Correction to: Identification of TAZ as the essential molecular switch in orchestrating SCLC phenotypic transition and metastasis.
Natl Sci Rev
; 10(12): nwac224, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-38155833
18.
Distinct Genetically Determined Origins of Myd88/BCL2-Driven Aggressive Lymphoma Rationalize Targeted Therapeutic Intervention Strategies.
Blood Cancer Discov
; 4(1): 78-97, 2023 01 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36346827
19.
Somatic rearrangements causing oncogenic ectodomain deletions of FGFR1 in squamous cell lung cancer.
J Clin Invest
; 133(21)2023 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37606995
20.
Overcoming drug resistance in ALK-rearranged lung cancer.
N Engl J Med
; 370(13): 1250-1, 2014 Mar 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-24670172